Search research articles
Contact Us
Filters
Showing results (41-50 of 167) with videos related to
Page
of 17
Sort By:
Clinical Chemistry and Laboratory Medicine
|
July 20, 2007
Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
Loredan Stefan Niculescu, Jamila Fruchart-Najib, Jean-Charles Fruchart, et al.
The Journal of Biological Chemistry
|
July 16, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes
Christophe Blanquart, Olivier Barbier, Jean-Charles Fruchart, et al.
Biochemical and Biophysical Research Communications
|
June 5, 2004
Different ways to regulate the PPARalpha stability
Christophe Blanquart, Roxane Mansouri, Jean-Charles Fruchart, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 21, 2006
Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence
Alberto Zambon, Philippe Gervois, Paolo Pauletto, et al.
Current Medical Research and Opinion
|
August 25, 2004
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C
M John Chapman, Gerd Assmann, Jean-Charles Fruchart, et al.
Biochimica Et Biophysica Acta
|
April 13, 2007
Safety issues and prospects for future generations of PPAR modulators
Anne Rubenstrunk, Rémy Hanf, Dean W Hum, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 8, 2004
The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha
Christophe Blanquart, Roxane Mansouri, Réjane Paumelle, et al.
Journal of Cardiovascular Pharmacology
|
April 13, 2004
Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism
Gérald Luc, Nelly Jacob, Muriel Bouly, et al.
Annals of Medicine
|
February 2, 2006
Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Heidelinde Jakel, Maxime Nowak, Audrey Helleboid-Chapman, et al.
Biochimica Et Biophysica Acta
|
February 8, 2003
SR-BI does not require raft/caveola localisation for cholesteryl ester selective uptake in the human adrenal cell line NCI-H295R
Olivier Briand, Sophie Lestavel, Antoine Pilon, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 167) with videos related to
Sort By:
Page
of 17
Clinical Chemistry and Laboratory Medicine
|
July 20, 2007
Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
Loredan Stefan Niculescu, Jamila Fruchart-Najib, Jean-Charles Fruchart, et al.
The Journal of Biological Chemistry
|
July 16, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes
Christophe Blanquart, Olivier Barbier, Jean-Charles Fruchart, et al.
Biochemical and Biophysical Research Communications
|
June 5, 2004
Different ways to regulate the PPARalpha stability
Christophe Blanquart, Roxane Mansouri, Jean-Charles Fruchart, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 21, 2006
Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence
Alberto Zambon, Philippe Gervois, Paolo Pauletto, et al.
Current Medical Research and Opinion
|
August 25, 2004
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C
M John Chapman, Gerd Assmann, Jean-Charles Fruchart, et al.
Biochimica Et Biophysica Acta
|
April 13, 2007
Safety issues and prospects for future generations of PPAR modulators
Anne Rubenstrunk, Rémy Hanf, Dean W Hum, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 8, 2004
The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha
Christophe Blanquart, Roxane Mansouri, Réjane Paumelle, et al.
Journal of Cardiovascular Pharmacology
|
April 13, 2004
Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism
Gérald Luc, Nelly Jacob, Muriel Bouly, et al.
Annals of Medicine
|
February 2, 2006
Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Heidelinde Jakel, Maxime Nowak, Audrey Helleboid-Chapman, et al.
Biochimica Et Biophysica Acta
|
February 8, 2003
SR-BI does not require raft/caveola localisation for cholesteryl ester selective uptake in the human adrenal cell line NCI-H295R
Olivier Briand, Sophie Lestavel, Antoine Pilon, et al.
Page
of 17